Volume 35, Issue 16, 21 April 2014

CardioPulse Articles

• Extract
• View article
• Supplementary data

Relaxing from dyspnoea

• Extract
• View article

Negating the dominant-negative allele: a new treatment paradigm for arrhythmias explored in human induced pluripotent stem cell-derived cardiomyocytes

• Extract
• View article
• Supplementary data

Mitral cleft repair by mitraclipping

• Extract
• View article
• Supplementary data

Heart failure with preserved ejection fraction: a clinical dilemma

• Abstract
• View article
• Supplementary data

Inter-atrial shunt inversion by the sitting position in a patient with a patent foramen ovale and acute pulmonary embolism

• Extract
• View article
• Supplementary data

Stress echo applications beyond coronary artery disease

• Abstract
• View article
• Supplementary data

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

• Abstract
• View article
• Supplementary data

Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy

• Abstract
• View article
• Supplementary data

High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression

• Abstract
• View article
• Supplementary data

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy

• Abstract
• View article
• Supplementary data

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes

• Abstract
• View article
• Supplementary data